Faron Pharmaceuticals Oy (FARN.L)
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company.
42.00+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-78.2%
The outlook
Faron Pharmaceuticals Oy currently reads as neutral based on strong buy — 1.0 avg of 1 analysts, below its 50- & 200-day averages, 2% of the way from its 52-week low to high, avg target +2281% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 1 analysts
Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Price targetAvg target +2281% vs current price
Market cap
$85.2M
52-wk high
240.00
52-wk low
38.00
50-day avg
42.87
200-day avg
97.51
Trailing P/E
—